Autophagy is a lysosome-dependant intracellular degradation process that eliminates long-lived proteins as well as damaged organelles from the cytoplasm. An increasing body of evidence suggests that dysregulation of this system plays a pivotal role in the etiology and/or progression of neurodegenerative diseases including motor neuron disorders. Herein, we review the latest findings that highlight the involvement of autophagy in the pathogenesis of amyotrophic lateral sclerosis (ALS) and the potential role of this pathway as a target of therapeutic purposes. Autophagy promotes the removal of toxic, cytoplasmic aggregate-prone pathogenetic proteins, enhances cell survival, and modulates inflammation. The existence of several drugs targeting this pathway can facilitate the translation of basic research to clinical trials for ALS and other motor neuron diseases.
Autophagy in motor neuron disease: Key pathogenetic mechanisms and therapeutic targets / M.S. Cipolat Mis, S. Brajkovic, E. Frattini, A. Di Fonzo, S. Corti. - In: MOLECULAR AND CELLULAR NEUROSCIENCES. - ISSN 1044-7431. - 72(2016), pp. 84-90.
Autophagy in motor neuron disease: Key pathogenetic mechanisms and therapeutic targets
S. BrajkovicSecondo
;E. Frattini;A. Di FonzoPenultimo
;S. Corti
2016
Abstract
Autophagy is a lysosome-dependant intracellular degradation process that eliminates long-lived proteins as well as damaged organelles from the cytoplasm. An increasing body of evidence suggests that dysregulation of this system plays a pivotal role in the etiology and/or progression of neurodegenerative diseases including motor neuron disorders. Herein, we review the latest findings that highlight the involvement of autophagy in the pathogenesis of amyotrophic lateral sclerosis (ALS) and the potential role of this pathway as a target of therapeutic purposes. Autophagy promotes the removal of toxic, cytoplasmic aggregate-prone pathogenetic proteins, enhances cell survival, and modulates inflammation. The existence of several drugs targeting this pathway can facilitate the translation of basic research to clinical trials for ALS and other motor neuron diseases.File | Dimensione | Formato | |
---|---|---|---|
1-s2.0-S1044743116300124-main for my air.pdf
accesso aperto
Tipologia:
Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione
579.38 kB
Formato
Adobe PDF
|
579.38 kB | Adobe PDF | Visualizza/Apri |
1-s2.0-S1044743116300124-main.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
493.56 kB
Formato
Adobe PDF
|
493.56 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.